RxLightning
Expediting Specialty Medication Access
RxLightning is creating a world in which every patient has accelerated access to the specialty medications they need, through a single, automated platform. In 2023, the team launched the MedAccess Ecosystem, which seamlessly connects all stakeholders from across the medication access journey, including manufacturers, providers, patients, hubs, pharmacies, and more.
This solution creates a standard onboarding experience for every specialty drug—reducing decision fatigue for providers. Additional features include fully digital and customizable enrollment forms, patient consent collection, benefits verification, coverage/cost details, prior authorization, affordability options, and more.
In most cases, vendors tackle one aspect of the medication onboarding process. RxLightning’s engineering and development teams spent a year working with key pharma and provider partners to understand prescribing workflows and build a solution that supports a better enrollment experience from start to finish. Josh Flum, Managing Partner at LRVHealth said, “RxLightning has gone far beyond creating a digital experience that replaces paper forms, and has created a first-of-its-kind ecosystem that connects every part of the specialty medication process.”
RxLightning is already improving the lives of patients who rely on life-saving specialty medications. These patients now have access to the therapies they need, faster and more affordably than ever before. The platform also relieves the growing problem of burnout among HCPs.
While RxLightning has already digitized the enrollment process for more than 1,500 specialty medications, over the next five years the company plans to extend its reach in the specialty medication market, develop deeper partnerships with pharma manufacturers to include discount options and financial assistance programs, and increase the number of specialty pharmacies in RxLightning’s network.
